Yang Ming-Gen, Zhao Xiao-Kun
Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Zhonghua Nan Ke Xue. 2008 Dec;14(12):1130-4.
So far the etiology of chronic prostatitis (PC) and particularly chronic pelvic pain syndrome (CPPS) remains to be elucidated. According to recent epidemiologic data, CP is the most common urological disease in men below 50 years and occurs in 2.5%-16.0% of the world population. Since the 1990s, researchers of many countries have carried out deeper, more extensive and larger scaled studies than ever before on the etiology, diagnosis and treatment of the disease, with the sponsorship and coordination of such international institutions as the International Prostatitis Collaborative Network (IPCN), the Chronic Prostatitis Collaborative Research Network of the National Institute of Health (NIH-CPCRN) and so on. As prevalent as multiple sclerosis, CPPS is the most common yet most poorly understood "prostatitis syndrome". This article reviews the progress in the studies of the treatment of CPPS, explores the main problems and ventures the prospects for the development in this field.
到目前为止，慢性前列腺炎（PC）尤其是慢性盆腔疼痛综合征（CPPS）的病因仍有待阐明。根据最近的流行病学数据，慢性前列腺炎是50岁以下男性中最常见的泌尿系统疾病，全球发病率为2.5%-16.0%。自20世纪90年代以来，在国际前列腺炎协作网络（IPCN）、美国国立卫生研究院慢性前列腺炎协作研究网络（NIH-CPCRN）等国际机构的赞助和协调下，许多国家的研究人员对该疾病的病因、诊断和治疗进行了比以往更深入、更广泛、更大规模的研究。CPPS与多发性硬化症一样普遍，是最常见但了解最少的“前列腺炎综合征”。本文综述了CPPS治疗研究的进展，探讨了主要问题，并展望了该领域的发展前景。
